Skip to main content

PEAK6 LLC

Position in MRNA — Moderna, Inc.

CIK 1389958 AUSTIN, TX

Position in MRNA

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$3,077,616
+$236,078 QoQ
Shares Held
60,583
-37.1% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Mar 31, 2026
CallValue
$8,041,640
CallShares
158,300
PutValue
$15,326,360
PutShares
301,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

PEAK6 LLC holds $24,388,144 across 19 Biotechnology names. MRNA ranks #4 (12.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 MRNA
Moderna, Inc.
This page
60,583 $3,077,616

All Filings in MRNA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,077,616 60,583
2026-03-31 $8,041,640 158,300
2026-03-31 $15,326,360 301,700
2025-12-31 $209,379 7,100
2025-12-31 $16,027,815 543,500
2025-12-31 $2,841,538 96,356
2025-09-30 $183,393 7,100
2025-09-30 $3,215,344 124,481
2025-09-30 $13,405,770 519,000
2025-06-30 $797,351 28,900
2025-06-30 $8,667,067 314,138
2025-06-30 $23,352,176 846,400
2025-03-31 $22,450,365 791,900
2025-03-31 $7,519,837 265,250
2025-03-31 $18,909,450 667,000
2024-12-31 $6,216,210 149,500
2024-12-31 $16,232,832 390,400
2024-12-31 $6,350,014 152,718